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http:WHAT THIS PAPER ADDS
There is a clinical equipoise about the best treatment for a patient with a ruptured abdominal aortic aneurysm:
endovascular (EVAR) or open repair (OR). The results of the present systematic review indicate that endovas-
cular aneurysm repair is not inferior to open repair with regard to short-term survival. This supports the use of
EVAR in suitable patients and OR as a reasonable alternative. Possible future directions are centralisation of care
in high-volume hospitals, ‘EVAR-ﬁrst’/hybrid repair, or an ‘EVAR-only’ approach.Background: There is clinical equipoise between open (OR) and endovascular aneurysm repair (EVAR) for the
best treatment of ruptured abdominal aortic aneurysm (RAAA).
Objective: The aim of the study was to perform a systematic review and meta-analysis to estimate the short-term
(combined 30-day or in-hospital) survival after EVAR and OR for patients with RAAA. Data sources included
Medline, Embase, and the World Health Organization International Clinical Trials Registry until 13 January 2014.
All randomised controlled trials (RCTs), observational cohort studies, and administrative registries comparing OR
and EVAR of at least 50 patients were included. Articles were full-length and in English.
Methods: Standard PRISMA guidelines were followed. The methodological quality of RCTs was assessed with the
Cochrane Collaboration’s tool for assessing risk of bias. The quality of observational studies was assessed with a
modiﬁed Cochrane Collaboration’s tool for assessing risk of bias, the NewcastleeOttawa Scale, and the
Methodological Index for Non-Randomized Studies. The results of the RCTs, of the obersvational studies, and of
the administrative registries were pooled separately and analysed with the use of a random effects model.
Results: From a total of 3,769 articles, three RCTs, 21 observational studies, and eight administrative registries
met the inclusion criteria. In the RCTs, the risk of bias was lowest and the pooled odds ratio for death after EVAR
versus OR was 0.90 (95% CI 0.65e1.24). The majority of the observational studies had a high risk of bias and the
pooled odds ratio for death was 0.44 (95% CI 0.37e0.53). The majority of the administrative registries had a high
risk of bias and the pooled odds ratio for death was 0.54 (95% CI 0.47e0.62).
Conclusion: Endovascular aneurysm repair is not inferior to open repair in patients with a ruptured abdominal
aortic aneurysm. This supports the use of EVAR in suitable patients and OR as a reasonable alternative.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd.
Article history: Received 17 January 2014, Accepted 4 March 2014, Available online 18 April 2014
Keywords: Open repair, Endovascular aneurysm repair
MeSH keywords: Abdominal Aortic Aneurysm, Aortic Rupture, Vascular Surgical Procedures
Open access under CC BY-NC-ND license.pendix 1: protocol, quality assessment RCTs, quality assessment
ational studies and administrative registries, search PubMed, search
, Figs. 7e10.
To access continuing medical education questions on this paper,
go to www.vasculareducation.com and click on ‘CME’
th authors equally contributed to current manuscript.
rresponding author. R. Balm, Department of Vascular Surgery, Aca-
Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The
lands.
il address: r.balm@amc.nl (R. Balm).
-5884  2014 European Society for Vascular
. Published by Elsevier Ltd.
//dx.doi.org/10.1016/j.ejvs.2014.03.003
Open access under CC BY-NC-ND license.INTRODUCTION
The death rate in all patients with a ruptured abdominal
aortic aneurysm (RAAA) is around 80%.1 One-third of all
patients with RAAA do not reach the hospital alive, and
one-third do not have an intervention. Of the patients
having an intervention, only half survive intervention and
admission. The traditional intervention is open surgical
repair (OR) with exclusion of the aneurysm with a synthetic
tube or bifurcated graft. Endovascular aneurysm repair
(EVAR) was developed in the 1990s. The experience with
elective EVAR has led to its increasing use in the emergency
setting. Between 46% and 64% of patients with RAAA have
suitable aortic anatomy for EVAR.2,3
594 S.C. van Beek et al.Observational studies have reported improved short-
term survival after EVAR compared with OR. Observa-
tional studies however have methodological limitations,
leading to biased estimates of outcome. Randomised
controlled trials are regarded as providing the best evidence
for the relative efﬁcacy of interventions. An early trial from
the UK did not show any beneﬁt of EVAR in patients with
RAAA.4 Recently, the results of two larger RCTs have been
published.2,3 These new studies might help to better
determine whether EVAR improves short-term survival
when compared with open repair, which in turn might help
caregivers to decide on the best treatment strategy.
OBJECTIVE
The aim of this study was to perform a systematic review
and meta-analysis to obtain the best estimates of the short-
term (combined 30-day or in-hospital) survival after endo-
vascular repair compared with open repair for patients with
a RAAA in randomised controlled trials and observational
studies.
METHODS
The present review was conducted according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines.5 The objectives, the
methodology, and the inclusion criteria were prespeciﬁed in
a protocol (Appendix 1).
Search strategy
A systematic search in Medline through Pubmed and in
Embase through Ovid was conducted with the assistance of
a clinical librarian. The search strategy was built around the
participants, intervention, comparison, outcomes, and
study design (PICOS) framework (Appendix 1). Additionally,
the World Health Organization International Clinical Trials
Registry Platform (WHOICTRP) was searched for relevant
RCTs.
The last search was done on the 13 January 2014. Two
authors (SvB, AC) independently screened the titles and
abstracts of the identiﬁed articles for relevance. Subse-
quently, the relevant full length articles were assessed by
two authors (SvB, AC) to check if they met the inclusion
criteria. Disagreements were resolved by discussion with
two other authors (MK, RB). The reference list of the
included articles was checked for other eligible articles and
a cited reference search in the Web of Science was done.
Eligibility criteria
All RCTs comparing OR and EVAR, and all observational
studies comparing OR and EVAR that included at least 50
patients were included. Observational studies that included
patients based on the International Classiﬁcation of Dis-
eases (ICD) or other forms of coding were analysed sepa-
rately, and are referred to as administrative registries.
Studies were included if they were full length and in English.
Studies reporting more than once on the same patient
population were included only once, based on relevanceand size. Studies were excluded if they did not allow
extraction of two-by-two contingency tables for the
endpoint 30-day or in-hospital death rate.
Assessment of study quality
The methodological quality of the included articles was
independently assessed by two authors (SvB, AC). For the
RCTs, The Cochrane Collaboration’s tool for assessing risk of
bias was used (Appendix 1). For the observational studies
and administrative registries, a tool based on the Cochrane
Collaboration’s tool for assessing risk of bias, the New-
castleeOttawa Scale, and the Methodological Index for
Non-Randomized Studies (MINORS) was used (Appendix).
Again, disagreements were resolved by discussion with two
other authors. The risk of bias within studies was reported
as an online supplement (Appendix 1, Figs. 7e9).
Data collection
Data were extracted independently by two authors (SvB,
AC) with use of a standardised form in Microsoft Ofﬁce
Access 2003 (Microsoft Corporation, Redmond, WA, USA).
The following data were collected: study design (RCT,
observational study or administrative registry), study
period, study size, country, and rejection rate. For the
included RCTs, the number of events and the total number
of patients per type of intervention were extracted based
on intention-to-treat analysis. For the included observa-
tional studies, the number of events and the total number
of patients per type of intervention were extracted based
on as-treated analysis. Authors were contacted to obtain
missing data if necessary. When the authors were unable to
provide missing data, the study was excluded from the
analysis.
Statistical analysis
The primary endpoint was the combined 30-day and in-
hospital death rate. If not reported, the 30-day or in-
hospital death rate was used instead. For the observa-
tional studies, a secondary endpoint was the odds ratio of
EVAR on death rate after adjustment for age, sex, and he-
modynamic stability. The statistical analysis was performed
using Review Manager 5.2 (Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration) and Stata/SE
11.0 (StataCorp, College Station, TX, USA). Three meta-
analyses were done. The ﬁrst meta-analysis included all
RCTs, the second all observational studies, and the third all
administrative registries. Pooled effects of EVAR and OR
were presented as odds ratios with 95% CI. Because het-
erogeneity was expected, the meta-analyses were done a
priori with the use of a random effects model. A pre-
speciﬁed sensitivity analysis of observational studies was
done by pooling the odds ratios of EVAR versus OR adjusted
for at least, age,6 sex,7 and hemodynamic stability.8 Het-
erogeneity between studies was determined with the I2
statistic. An I2 between 30% and 50% was considered
moderate heterogeneity and between 60% and 90% as
substantial heterogeneity. Funnel plots were created and
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10 studies were included.RESULTS
Literature search
3,769 unique articles were identiﬁed from Medline and
Embase, of which 123 were retrieved for more detailed
evaluation and 30 met the inclusion criteria (Fig. 1). Two
additional RCTs2,9 were identiﬁed from the WHO ICTRP, of
which one was published2 and included. One additional
administrative registry10 was identiﬁed from the cited
reference search. Of 32 included studies, three articles were
RCTs,2e4 21 were observational studies,6,11e30 and eight
were administrative registries.10,31e38 Table 1 summarises
their main characteristics.Figure 1. Flowchart ofStudy quality
The quality assessment of the included studies is summar-
ised in Figs. 2e4 and in Figs. 6e9 of the appendix. The risk of
bias was lowest in the RCTs, whereas the observational
studies suffered from all forms of bias. In >75% of obser-
vational studies the representativeness of the cohort, the
blinding of outcome assessment and the baseline equiva-
lence of groups was considered to have a high risk of bias. In
all observational studies, patient selection for EVAR and OR
was considered to have a high risk of bias because treatment
was based on the preference of caregivers or a clinical al-
gorithm. The administrative registries also suffered from all
forms of bias. In more than 50% of the registries the repre-
sentativeness of the cohort was considered to have a high
risk of bias, mostly because of lack of information about the
type of hospitals (secondary, tertiary) included.in- and exclusion.
Table 1. Characteristics of studies included in the meta-analyses evaluating the outcome after endovascular and open repair of a ruptured
abdominal aortic aneurysm.
Study Country Study
design
Study period Number of
patients
Rejection rate Type death
rate
Death rate
EVAR (CI)
Death rate
OR (CI)
Nottingham 2006 United Kingdom RCT 2002e2004 32 54% (55/103) 30-day 53% (30e75) 53% (31e74)
AJAX 2013 The Netherlands RCT 2004e2011 116 9% (46/520) 30-day or IH 28% (18e41) 29% (19e41)
IMPROVE 2014 United Kingdom RCT 2009e2013 613 23% (299/1275) 30-day 32% (27e37) 35% (30e40)
Coppi 2006 Italy OS 1999e2006 124 Not reported 30-day 30% (17e47) 46% (36e56)
Peppelenbosch 2006 Multiplec OS 2003e2004 100 Not reported 30-day or IH 35% (23e49) 39% (27e53)
Acosta 2007 Sweden OS 2000e2004 162 24% (51/213) IH 34% (23e47) 45% (36e55)
Ockert 2007 Germany OS 2000e2005 58 Not reported 30-day 31% (17e49) 31% (17e49)
Moore 2007 Canada OS 2004e2006 56 Not reported 30-day 5% (1e24) 25% (14e41)
Sharif 2007 United Kingdom OS 2001e2006 126 10% (14/140) 30-day or IH 33% (22e46) 51% (40e62)
Lee 2008 USA OS 2002e2006 52 Not reported 30-day or IH 35% (17e59) 63% (46e77)
Verhoeven 2009 The Netherlands OS 2002e2009 159 9% (16/175) 30-day or IH 20% (11e34) 35% (27e44)
Chagpar 2010 Canada OS 2003e2008 167 Not reported 30-day 16% (7e32) 44% (36e52)
Cho 2010 USA OS 2001e2008 233 Not reported 30-day or IH 20% (7e45) 38% (32e45)
Sarac 2011 USA OS 1990e2008 160 Not reported 30-day or IH 31% (18e49) 32% (25e41)
Van Schaik 2011 The Netherlands OS 2006e2008 56 3% (2/58) 30-day 27% (11e52) 46% (32e61)
Bosch 2012 The Netherlands OS 2002e2008 129 4% (6/135) 30-day 20% (9e39) 45% (36e55)
Mayer 2012 Multipled OS 1998e2011 431 10% (42/473) 30-day 18% (14e23) 37% (30e45)
Noorani 2012 United Kingdom OS 2006e2010 102 8% (9/111) IH 12% (5e23) 28% (17e42)
Rödel 2012 The Netherlands OS 2006e2010 105 10% (12/117) 30-day 17% (8e33) 31% (22e43)
Saqib 2012 USA OS 2001e2011 148 Not reported 30-day or IH 22% (11e37) 32% (24e41)
Eefting 2013 The Netherlands OS 2002e2012 195 Not reported 30-day 24% (16e35) 52% (43e61)
Mehta 2013 USA OS 2002e2011 283 Not reported 30-day 24% (17e33) 44% (37e52)
Mukherjee 2013a USA OS 2007e2011 50 Not reported 30-day 27% (15e43) 15% (4e42)
Wallace 2013 USA OS 2007e2012 100 15% (18/118)b IH 16% (9e28) 46% (32e61)
Greco 2006 USA AR 2000e2003 5,798 Not reported IH 39% (34e45) 48% (46e49)
Wanhainen 2008 Sweden AR 1994e2005 3,516 Not reported 30-day 15% (9e24) 36% (35e38)
Giles 2009 USA AR 2005e2007 567 Not reported 30-day 24% (17e32) 36% (32e41)
Holt 2010 United Kingdom AR 2003e2008 4,414 Not reported IH 32% (27e37) 47% (46e49)
Mani 2011 Multiplee AR 2005e2009 7,040 Not reported 30-day or IH 20% (17e23) 33% (31e34)
Chen 2013 Taiwan AR 1998e2009 537 Not reported IH 44% (29e59) 38% (34e43)
Mohan 2013 USA AR 2001e2010 42,126 Not reported IH 26% (25e27) 39% (38e40)
Trenner 2013 Germany AR 1999e2010 4,859 Not reported IH 23% (20e26) 41% (40e43)
USA ¼ United States of America; OS ¼ observational study; RCT ¼ randomised controlled trial; AR ¼ administrative registry;
EVAR ¼ endovascular aneurysm repair; IH ¼ in-hospital; OR ¼ open repair; CI ¼ 95% conﬁdence interval.
a Patients treated with hybrid repair included in open repair group.
b 10 patients died during unknown intervention.
c Belgium, Canada, Finland, Italy, Netherlands and Northern Ireland.
d Sweden, Switzerland.
e Australia, Denmark, Finland, Hungary, Italy, Norway, Sweden, Switzerland, United Kingdom.
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In the RCTs, the reported death rates ranged between 28%
and 53% after EVAR and between 29% and 53% after OR.
The pooled odds ratio for death after EVAR versus OR was
0.90 (95% CI 0.65e1.24) (Fig. 5). No funnel plot was created
because of the low number of included RCTs.
In the observational studies, the death rates after EVAR
ranged between 5% and 35% and between 15% and 63%
after OR. The pooled odds ratio for death after EVAR versus
OR was 0.44 (0.37e0.53) (Fig. 5). There were no signs of
asymmetry in the funnel plot (Appendix 1, Fig. 10). In the
sensitivity analysis of observational studies adjusting for
age, sex, and haemodynamic stability, the pooled adjusted
odds ratio of EVAR versus OR was 0.53 (95% CI 0.29e0.98)
with moderate heterogeneity among the studies (I2 ¼ 34%)
(Fig. 6).In the administrative registries, the death rates after
EVAR ranged between 15% and 39% and between 33% and
48% after OR. The pooled odds ratio for death after EVAR
versus OR was 0.54 (95% CI 0.47e0.62) (Fig. 5). There was
moderate heterogeneity in outcomes among the adminis-
trative registries (I2 ¼ 67%). No funnel plots were created
because of the low number of included administrative
registries.
DISCUSSION
The present systematic review expands upon previous re-
views39e48 considering EVAR versus OR for patients with
RAAA in two ways. First, this is the ﬁrst to include three
RCTs. Second, only one previous systematic review also
included a thorough study quality assessment. The results of
the meta-analyses presented here indicate that EVAR is not
Figure 2. Risk of bias randomised controlled trials.
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This supports the use of EVAR in suitable patients and OR as
reasonable alternative.
Study quality
There was a conspicuous contradiction between the pooled
results of the RCTs, the observational cohort studies and the
administrative registries. The pooled results of the obser-
vational studies and administrative registries show that
EVAR improves short-term survival. However, in the pooled
results of the RCTs these results were not conﬁrmed. For
this reason, we are reluctant to draw the conclusion that
short-term survival is lower after EVAR than after OR.
The disparate results are most likely explained by study
quality and selection bias. The study quality assessment
clearly showed that the RCTs had the least risk of bias for
the comparison of EVAR and OR. Treatment allocation by
caregivers and thereby selection of patients for either
intervention is the most important risk of bias in observa-
tional studies. Treatment algorithms and surgeon’s decisions
resulted directly in OR in haemodynamically unstable pa-
tients and in preoperative computed tomographic angiog-
raphy and subsequent EVAR in haemodynamically stable
patients. By this selection, patients with a low-risk proﬁle
for survival were treated with OR and with a high-risk
proﬁle for survival with EVAR. In only three17,3,25 of 21
observational studies was the outcome adjusted for the
most important confounders age, sex, and haemodynamicFigure 3. Risk of bias obstability. The improved short-term survival after EVAR per-
sisted in the sensitivity analysis of the observational studies
adjusting for these confounders (odds ratio 0.53, 95% CI
0.29e0.98). Contrary to our expectations, these pooled
results did not mimic the outcomes of the RCTs. The
multivariate analyses may have been affected by residual
confounding, which means that statistical methods could
not eliminate all differences in observed and unobserved
confounders. On the other hand, the RCTs might have been
affected by selection bias before enrolment of patients,
thereby hampering comparison with daily practice.
The administrative registries with a low risk of bias
described their data quality checks and represented both
secondary and tertiary hospitals. These registries reﬂect the
daily practice of EVAR and OR over a longer time period and
are state-, nation-, or continent-wide. An advantage is that
referral patterns are automatically incorporated in the re-
sults. However, rejection rates and detailed patient char-
acteristics are scarcely available which are essential
elements of the direct comparison between EVAR and OR.
Moreover, accuracy of patient identiﬁcation with use of ICD
coding can be questioned.
Preferred intervention
The present review considers short-term survival. Although
this is the most important outcome for patients with RAAA,
other arguments might support either EVAR or OR. In
general, it might be argued that non-inferiority sufﬁces for aservational studies.
Figure 4. Risk of bias administrative registries.
598 S.C. van Beek et al.minimally invasive surgical technique compared with the
open equivalent. In the RCTs there appears to be a beneﬁt
for EVAR with regard to secondary outcomes like reduction
of intensive care unit and hospital stay, need for mechanical
ventilation, and blood loss.2,3 The number of in-hospitalFigure 5. Forest plot showing the pooled odds ratios of the randomis
istries comparing endovascular versus open repair in patients with a
Registry; NSQIP ¼ American College of Surgeons National Surgical Q
NHIRD ¼ National Health Insurance Research Database; NIS ¼ Nationreinterventions appears to be comparable.2,3 In the direct
comparison of costs after 30 days between EVAR and OR in
the AJAX trial, EVAR was V5,306 more expensive (95% CI
1,854e12,659).49 In the comparison of costs after 30 days
between the endovascular and open strategy in theed controlled trials, observational studies, and administrative reg-
ruptured abdominal aortic aneurysm. SVR ¼ Swedish Vascular
uality Improvement Program; HES ¼ Hospital Episode Statistics;
wide Inpatient Sample; DGG ¼ German Vascular Society.
Figure 6. Sensitivity analysis of observational studies comparing endovascular vs. open repair after adjustment for at least age, sex, and
hemodynamic stability.
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cheaper (95% CI 3,626e756).2 These seemingly contradic-
tory outcomes can be explained in the IMPROVE trial by the
112/275 patients treated by open surgery in the endovas-
cular strategy group, by shorter stay in the intensive care
unit and hospital, and by a cheaper endograft. Yet, the re-
sults are not contradictory if it is argued that EVAR is more
expensive than OR but that a treatment strategy offering
both EVAR and OR is not more expensive than a treatment
strategy including only OR. Although it is of importance in
decision-making, few data are available on surgeons and
patient preferences. Finally, in elective aortic surgery, the
long-term risk of reinterventions and aneurysm rupture is
higher after EVAR than after OR.50 A recent observational
study in patients with RAAA reported a higher late rein-
tervention rate after EVAR (16/62, median follow-up 42
months with an interquartile range 4e76) than after OR (4/
85, median follow-up 39 months with an interquartile range
2e75) (p ¼ .008).51 More data are needed before deﬁnite
conclusions can be drawn with regard to long-term out-
comes. However, one might question whether long-term
risks should impact decision-making in the acute clinical
setting and EVAR for RAAAs could be considered a damage
control intervention.Future directions
What are the future directions after the present review?
Currently, there is still one RCT underway aiming to
compare EVAR versus OR,9 which might change the pooled
results. Based on the results from the currently available
RCTs that show small differences in short-term survival, it
seems unlikely that a new RCT will show marked differ-
ences. To our current knowledge the clinical equipoise on
short-term survival will remain and the differences between
EVAR and OR should be found in the secondary and long-term outcomes. The aggregated results from the RCTs, the
observational studies and administrative registries guide us
to the conclusion that EVAR is a good choice in patients that
are anatomically and clinically ﬁt for endovascular repair. In
other patients OR is a reasonable alternative.
Speciﬁc patient groups could be studied: EVAR might be
more beneﬁcial in women2 and OR might be more beneﬁ-
cial in patients with hostile aortic anatomy. Although a
detailed description runs beyond the scope of the present
review, several studies gave other future directions of care
for patients with RAAA. Centralisation of care in high-
volume hospitals was suggested in four of 30
studies.3,19,33,34 Two studies proposed ‘EVAR-ﬁrst’ or hybrid
repair comprising rapid proximal aortic balloon occlusion in
all patients and subsequently EVAR or OR.20,30 Another
study suggested an ‘EVAR-only’ approach and treated 70 of
73 consecutive RAAA patients with EVAR.17 These sugges-
tions are promising, but much research needs to be done
before deﬁnite conclusions can be drawn.
Finally, the most important beneﬁt of EVAR might be that
patients who were considered unﬁt for open surgical repair
earlier might be considered eligible for endovascular inter-
vention nowadays. This leads to an increase in the number
of treated patients, which might explain the improved
population-based survival that was found in a recent sys-
tematic review.1 Another indication of a reduction of
rejection rates is a trend towards older patients being
treated for RAAAs in administrative registries35,37 However,
meta-regression of the study midpoint dates and rejection
rates showed no signiﬁcant trend over time (data not
shown). Therefore, more high-quality data are needed
before deﬁnite conclusions can be drawn and the present
systematic review cannot answer the question of a reduc-
tion in rejection rates. Moreover, a reduction in rejection
rates might be caused by EVAR but also by permissive hy-
potension during transport, massive transfusion protocols,
600 S.C. van Beek et al.specialised cardiovascular anaesthetic care, and improve-
ments in the intensive care unit.
Limitations
An important limitation of this systematic review is that it
might have been affected by publication bias. No funnel
plots of the RCTs or administrative registries could be
created because of the low number of studies. Data might
have been missed since one eligible study was excluded
because of language restrictions and one because data were
missing and could not be provided by the corresponding
author. The impact of publication bias on the conclusions is
difﬁcult to assess. In general, publication bias leads to an
overestimation of treatment effect.
An important limitation of the meta-analysis of the RCTs
is that it included only 761 patients. The low number of
patients limits the external validity of outcomes for the
general RAAA population. It is concluded that EVAR is not
inferior to OR. Based on an expected survival rate after
EVAR of 68% and after OR of 65% and assuming an a of 5%
and a b of 80%, the sample size needed for a hypothetical
non-inferiority trial would be 680 patients for a margin of
6% and 860 patients for a margin of 5%. Assuming a survival
rate of 65% after OR, the margin of this non-inferiority
conclusion includes a survival after EVAR of at least 59%
(65 minus 6%). It could be argued that this margin is too
wide and more patients are needed to decrease the margin.
However, given the pooled results of EVAR from the RCTs,
observational studies, and administrative registries it is
considered highly unlikely that the survival of EVAR is worse
than 59%. The inclusion of the IMPROVE trial troubled our
statistical analysis. From this RCT, only the surgically treated
RAAA patients were included, and this violated the
intention-to-treat principle to reduce bias from patients
with no RAAA and patients without treatment. Inclusion of
non-surgically treated RAAA patients (n ¼ 36) and patients
with other diseases (n ¼ 55) was considered inappropriate.
Noteworthy, after including all patients from the IMPROVE
trial the pooled odds ratio of the RCTs barely differed (0.93,
95% CI 0.69e1.25).
CONCLUSION
The results of the present systematic review, meta-analyses,
and study quality assessment indicate that EVAR is not
inferior to OR in patients with a ruptured abdominal aortic
aneurysm with regard to short-term survival. This supports
the use of EVAR in suitable patients and OR as reasonable
alternative.
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